Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

Teo Min Yuen; Mota Jose Mauricio; Whiting Karissa A.; Li Han A.; Funt Samuel A.; Lee Chung-Han; Solit David B.; Al-Ahmadie Hikmat; Milowsky Matthew I; Balar Arjun V; Pietzak Eugene; Dalbagni Guido; Bochner Bernard H.; Ostrovnaya Irina; Bajorin Dean F.; Rosenberg Jonathan E.; Iyer Gopa

首页> 外文期刊>European urology >Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

【24h】

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

机译：成纤维细胞生长因子受体3改变状态与局部晚期和转移性尿路上皮癌的铂化疗的差异敏感性相关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Alterations in fibroblast growth factor receptor 3 (FGFR3) occur in similar to 15% of muscle-invasive bladder cancers (MIBCs) and metastatic urothelial carcinomas (mUCs).

机译：None

著录项

来源
《European urology》 |2020年第6期|共9页
作者
Teo Min Yuen; Mota Jose Mauricio; Whiting Karissa A.; Li Han A.; Funt Samuel A.; Lee Chung-Han; Solit David B.; Al-Ahmadie Hikmat; Milowsky Matthew I; Balar Arjun V; Pietzak Eugene; Dalbagni Guido; Bochner Bernard H.; Ostrovnaya Irina; Bajorin Dean F.; Rosenberg Jonathan E.; Iyer Gopa;
展开▼
作者单位

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Epidemiol &

Biostat New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Pathol New York NY 10065 USA;

Univ N Carolina Lineberger Comprehens Canc Ctr Div Hematol Oncol Chapel Hill NC 27515 USA;

NYU Langone Hlth Dept Med Oncol New York NY USA;

Mem Sloan Kettering Canc Ctr Dept Surg Urol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Surg Urol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Surg Urol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Epidemiol &

Biostat New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

Mem Sloan Kettering Canc Ctr Dept Med Genitourinary Oncol Serv New York NY 10065 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
FGFR3; Urothelial cancer; Chemotherapy; Platinum;

机译：FGFR3;尿路上皮癌;化疗;铂金;

相似文献

外文文献
中文文献
专利

1. Changes in human epidermal growth factor receptor 2 status between primary breast/gastric carcinomas and synchronous metastatic lymph nodes: how can we explain them? [J] . Antonio Ieni, Valeria Barresi, Giovanni Branca, 癌症转移与治疗（英文版） . 2015,第001期
2. Advances in Variations of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor-2 Status in Metastatic Breast Cancer [J] . Yuan Yuan, Zhang Lili 国际转化医学杂志（英文版） . 2013,第002期
3. Research progress in the use of combinations of platinum-based chemotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors [J] . Chi Pan, Suzhan Zhang, Jianjin Huang 中德临床肿瘤学杂志（英文版） . 2013,第003期
4. Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907-15 Linking FGFR3 Mutation Status and Luminal Papillary Subtype to Response to Cisplatin-based Chemotherapy in Bladder Cancer [J] . Roumiguie Mathieu, Contreras-Sanz Alberto, Black Peter C. European urology . 2021,第6期

机译：Re：Ming Yuen Teo，Jose Mauricio Mota，Karissa A. Whiting等。成纤维细胞生长因子受体3改变状态与局部晚期和转移性尿路上皮癌的铂化疗的差异敏感性相关。 EUR UROL 2020; 78：907-15连接FGFR3突变状态和腔乳头状亚型，以应对膀胱癌的顺铂化疗
5. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma (vol 78, pg 907, 2020) [J] . Teo Min Yuen, Mota Jose Mauricio, Whiting Karissa A., European urology . 2021,第5期

机译：成纤维细胞生长因子受体3改变状态与基于铂的化学疗法的差异敏感有关（Vol 78，PG 907,2020）
6. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment [J] . Songbai Wang, Mike Burgess, Christopher Major, The Journal of Pathology: Clinical Research . 2020,第3期

机译：鉴定使用RNA的测定在转移或局部晚期，手术不可切除的尿路上皮癌患者中使用RNA的测定，核癌癌的成纤维细胞生长因子受体遗传改变
7. A COMPUTATIONAL MODEL OF FIBROBLAST GROWTH FACTOR-2 BINDING TO ISOLATED AND INTACT CELL SURFACE RECEPTORS: EFFECTS OF FIBROBLAST GROWTH FACTOR-2 CONCENTRATION, FLOW AND DELIVERY MODE [C] . Nisha S Patel, Alisa Morss Clyne ASME summer bioengineering conference;SBC2012 . 2012

机译：成纤维细胞生长因子-2与分离的完整细胞表面受体结合的计算模型：成纤维细胞生长因子-2浓度，流量和递送模式的影响
8. Broad-spectrum protection against chemotherapy-induced alopecia by acidic and basic fibroblast growth factors. [D] . Wang, Jie. 2005

机译：酸性和碱性成纤维细胞生长因子对化疗引起的脱发的广谱保护。
9. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced surgically unresectable urothelial carcinoma who may benefit from erdafitinib treatment [O] . Songbai Wang, Mike Burgess, Christopher Major, 2020

机译：使用基于RNA的检测方法鉴定可能受益于erdafitinib的转移性或局部晚期手术无法切除的尿路上皮癌患者中的成纤维细胞生长因子受体基因改变
10. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment [O] . Songbai Wang, Mike Burgess, Christopher Major, 2020

机译：鉴定使用RNA的测定在转移或局部晚期，手术不可切除的尿路上皮癌患者中使用RNA的测定，核癌癌的成纤维细胞生长因子受体遗传改变
11. Markers of Fibroblast Growth Factor Family-Mediated Growth Signal Transduction asDeterminants of Successful Hormonal Therapy for Patients with Estrogen Receptor Positive Breast Cancer [R] . Kern, F. G. 1995

机译：成纤维细胞生长因子家族介导的生长信号转导标志物作为雌激素受体阳性乳腺癌患者成功激素治疗的决定因素

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅